Ulrich Griesser

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Axams, AT (2011 - 2016)
Axamas, AT (2016)
Innsbruck, AT (2013 - 2024)

Company Filing History:

Lek Pharmaceuticals D.d.

patents

Years Active: 2011-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12043590 - Co-crystals comprising levothyroxine and a dicarboxylic acid (2024-07-23),

2. 10954235 - Crystalline forms of valbenazine salts (2021-03-23),

3. 10323056 - Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene (2019-06-18),

4. 9534004 - Crystalline forms of ceftaroline fosamil (2017-01-03),

5. 9499504 - Crystalline form of vortioxetine hydrobromide (2016-11-22),

6. 9440924 - Acetone solvate of ivabradine hydrochloride (2016-09-13),

7. 9266868 - Crystalline form of rivaroxaban dihydrate (2016-02-23),

8. 9145400 - Process for the preparation of form III of vilazodone hydrochloride (2015-09-29),

9. 8946441 - Polymorphs of an active pharmaceutical ingredient (2015-02-03),

10. 8563555 - Pharmaceutical compositions containing a crystalline form of posaconazole (2013-10-22),

11. 8435998 - Crystalline form of posaconazole (2013-05-07),

12. 8309769 - Crystalline forms of 2-[2-chloro-4-methylsulfony1-3-(2,2,2-trifluoroethoxymethyl)benzoyl]cyclohexan-1,3-dione (2012-11-13),

13. 8222380 - Amorphous telithromycin compound (2012-07-17),

14. 8008490 - Polymorphic forms of aripiprazole and method (2011-08-30),

Title: Ulrich Griesser: Innovator in Pharmaceutical Chemistry

Introduction

Ulrich Griesser is a prominent inventor based in Innsbruck, Austria, known for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, Griesser has made notable advancements in the field, particularly in the development of co-crystals and crystalline forms of pharmaceutical compounds.

Latest Patents

Griesser's latest patents include innovative formulations that have the potential to improve therapeutic outcomes. One of his key inventions is a co-crystal comprising levothyroxine and a dicarboxylic acid, specifically L-tartaric acid or oxalic acid. This invention not only details the composition but also outlines processes for its preparation. The pharmaceutical composition derived from this co-crystal is intended for use as a medicament, particularly for treating hypothyroidism. Another significant patent involves crystalline forms of valbenazine salts, focusing on valbenazine ditosylate. This invention includes both crystalline hydrate and anhydrate forms, along with methods for their preparation. The resulting pharmaceutical composition is aimed at treating hyperkinetic movement disorders, such as tardive dyskinesia.

Career Highlights

Throughout his career, Ulrich Griesser has worked with notable companies in the pharmaceutical industry, including Sandoz AG and BASF SE Corporation. His work has been instrumental in advancing drug formulations and improving patient care through innovative pharmaceutical solutions.

Collaborations

Griesser has collaborated with esteemed colleagues, including Christoph Langes and Andreas Hotter, contributing to a dynamic exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Ulrich Griesser's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to impact the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.